| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | GENB | United States | $13.40 | $0.00 | Strong Buy | 6 | N/A |
#2 | KYIV | United Arab Emirates | $13.40 | $0.00 | Strong Buy | 8 | N/A |
#3 | AUPH | Canada | $15.35 | $283,055,000.00 | Buy | 4 | 2014 |
#4 | MCHP | United States | $78.78 | $5,349,500,000.00 | Buy | 22 | 2004 |
#5 | SKYT | United States | $30.62 | $442,139,000.00 | Buy | 5 | 2021 |
#6 | AA | United States | $44.26 | $12,831,000,000.00 | Buy | 10 | 2016 |
#7 | INVA | United States | $21.44 | $217,217,000.00 | Buy | 5 | 2000 |
#8 | FLYW | United States | $15.89 | $623,025,000.00 | Buy | 14 | 2021 |
#9 | CSTM | France | $29.05 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#10 | BWMN | United States | $25.96 | $490,017,000.00 | Strong Buy | 4 | 2021 |
#11 | CECO | United States | $75.63 | $0.00 | Strong Buy | 4 | 2002 |
#12 | PTCT | United States | $76.82 | $264,734,000.00 | Buy | 17 | 2006 |
#13 | IREN | Australia | $37.16 | $501,023,000.00 | Buy | 11 | 2021 |
#14 | VIAV | United States | $39.49 | $1,084,300,000.00 | Strong Buy | 8 | 1996 |
#15 | ORN | United States | $12.69 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#16 | DSP | United States | $10.70 | $344,201,000.00 | Strong Buy | 8 | 2021 |
#17 | APEI | United States | $47.71 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#18 | DRVN | United States | $13.61 | $1,862,438,000.00 | Buy | 8 | 2020 |
#19 | SPIR | United States | $10.99 | $110,451,000.00 | Strong Buy | 5 | 2020 |
#20 | UPST | United States | $26.97 | $1,043,857,000.00 | Buy | 16 | 2020 |
#21 | PSTL | United States | $24.00 | $95,823,000.00 | Strong Buy | 4 | 2018 |
#22 | IPGP | United States | $91.70 | $1,003,777,000.00 | Strong Buy | 5 | 2000 |
#23 | HNRG | United States | $15.24 | $469,466,000.00 | Strong Buy | 4 | 1995 |
#24 | CPRI | United Kingdom | $15.43 | $3,474,000,000.00 | Buy | 13 | 2011 |
#25 | CCI | United States | $74.90 | $4,264,000,000.00 | Buy | 16 | 1998 |
#26 | PUMP | United States | $11.80 | $1,269,158,000.00 | Buy | 7 | 2017 |
#27 | LINC | United States | $40.51 | $261,853,000.00 | Strong Buy | 4 | 2005 |
#28 | DKNG | United States | $23.01 | $6,054,525,000.00 | Strong Buy | 31 | 2021 |
#29 | STOK | United States | $29.30 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#30 | PEGA | United States | $26.82 | $682,695,000.00 | Buy | 12 | 1996 |
#31 | ANAB | United States | $54.15 | $234,603,000.00 | Buy | 12 | 2015 |
#32 | BEAM | United States | $25.22 | $24,000.00 | Buy | 12 | 2019 |
#33 | KRUS | United States | $44.17 | $282,763,000.00 | Buy | 9 | 2019 |
#34 | ALGM | United States | $46.03 | $890,096,000.00 | Strong Buy | 11 | 2007 |
#35 | DGII | United States | $66.95 | $430,221,000.00 | Strong Buy | 5 | 1995 |
#36 | AROC | United States | $36.14 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#37 | ADEA | United States | $25.95 | $443,386,000.00 | Strong Buy | 4 | 2020 |
#38 | KGS | United States | $59.08 | $1,308,100,000.00 | Strong Buy | 7 | 2023 |
#39 | HCSG | United States | $22.74 | $1,837,173,000.00 | Buy | 6 | 1994 |
#40 | UTI | United States | $37.78 | $835,616,000.00 | Strong Buy | 4 | 2003 |
#41 | MXL | United States | $71.60 | $478,596,000.00 | Strong Buy | 6 | 2009 |
#42 | KDP | United States | $29.68 | $16,603,000,000.00 | Buy | 15 | 2007 |
#43 | IMUX | United States | $13.39 | $0.00 | Strong Buy | 6 | 2013 |
#44 | ZYME | United States | $22.86 | $105,965,000.00 | Strong Buy | 11 | 2022 |
#45 | CLFD | United States | $30.99 | $85,034,000.00 | Strong Buy | 4 | 1995 |
#46 | ALLY | United States | $42.92 | $7,914,000,000.00 | Strong Buy | 13 | 2011 |
#47 | ENTA | United States | $12.78 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#48 | NPCE | United States | $14.81 | $99,986,000.00 | Strong Buy | 6 | 2021 |
#49 | FSBC | United States | $46.81 | $0.00 | Buy | 5 | 2021 |
#50 | RMBS | United States | $96.01 | $707,630,000.00 | Buy | 7 | 1997 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (July 24, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.